Genmab AS - Company Profile

Powered by

All the sales intelligence you need on Genmab AS in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Genmab AS fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Genmab AS.

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on Genmab AS’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Genmab AS's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Deirdre P. Connelly

Chairman Executive Board Since: 2017 Age: 64

Ms. Deirdre P. Connelly has been the Chairman of the company since 2017. Prior to this, she served as the President of North America Pharmaceuticals for GlaxoSmithKline Plc from 2009 to 2015. Ms. Connelly also serves as the Director of Lincoln Financial Corporation and Macy’s Inc.

Read Hide full bio of Deirdre P. Connelly

Jan G. J. van de Winkel, Ph.D.

Chief Executive Officer; President Senior Management Since: 2010 Age: 64

Dr. Jan G.J. Van de Winkel has been the President and Chief Executive Officer of the company since 2010. Prior to this, he served as the Scientific Director and the Vice President of Medarex Europe. Mr. Winkel holds a professorship in Immunotherapy at Utrecht University.

Read Hide full bio of Jan G. J. van de Winkel, Ph.D.

Anthony Pagano

Executive Vice President; Chief Financial Officer Senior Management Since: 2020 Age: 48

Mr. Anthony Pagano has been the Executive Vice President and Chief Financial Officer of the company since 2020. Prior to this, he served as the Corporate Controller and Senior Director of Business Planning at NovaDel Pharma.

Read Hide full bio of Anthony Pagano

Martine J. van Vugt

Executive Vice President; Chief Strategy Officer Senior Management Since: 2023 Age: 55

Ms. Martine van Vugt has been the Executive Vice President and Chief Strategy Officer of the company since March 2023. Prior to this, she served as a Senior Vice President, Corporate Strategy & Planning.

Read Hide full bio of Martine J. van Vugt

Greg Mueller

Chief Legal Officer; General Counsel; Executive Vice President Senior Management Since: 2025

Mr.Greg Mueller has been the Executive Vice President, General Counsel & Chief Legal Officer of the company since 2025. Previously, he served as the orporate transactions lawyer at a large national Canadian law firm.

Read Hide full bio of Greg Mueller
Gain a 360-degree view of Genmab AS and make more informed decisions for your business Gain a 360-degree view of Genmab AS and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer